featured

featured

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • High hopes for major TB vaccine study recently launched in Paarl

    The world desperately needs an effective TB vaccine to reduce the illness and death still being caused by the centuries’ old bacterium. Chris Bateman visited a study site in Paarl where a promising experimental TB vaccine is now being tested as part of a large multi-country clinical trial.

    ·

  • Fears grow for R800 million cut to US funding of medical research in SA

    Medical researchers in South Africa are in limbo as they wait to hear whether over R800 million in research grants from the United States National Institutes of Health will be terminated. South Africa’s top universities, which receive the bulk of the funding, will be particularly hard hit if the cuts materialise. Catherine Tomlinson reports.

    ·

  • What does it mean for health? SAMRC experts weigh in on budget 2025

    While the 2025 national budget boosts health spending, researchers from the South African Medical Research Council stress the need for strong accountability measures. They also raise concerns about rising VAT and omissions related to US funding cuts and climate change.

    ·

  • How much does our HIV response depend on US funding?

    After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck than the government’s programmes. Jesse Copelyn looks past the 17% figure, and considers how the health system is being affected…

    ·

  • US funding cuts imperil search for HIV vaccine

    A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising vaccine candidates might not be tested in clinical trials. Catherine Tomlinson reports.

    ·

  • SA unveils ambitious new HIV campaign amid aid crisis

    Amid major disruptions caused by aid cuts from the United States government, the health department aims to enrol a record number – an additional 1.1 million – of people living with HIV on life-saving antiretroviral medicine this year. Experts tell Spotlight it can’t be business as usual if this ambitious programme is to have a…

    ·

  • Massive $200 million TB research programme derailed by US funding cuts

    Just over a month after US President Donald Trump implemented a 90-day freeze of all foreign assistance, the future looks very uncertain for tuberculosis research. Among others, a large TB research programme that was worth up to $200 million was axed last week. Elri Voigt reports.

    ·